ArticleFrontiers in public health2026
The need for measurable targets in national action plans on antimicrobial resistance: opportunities for action.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Antimicrobial resistance (AMR) represents a significant global health challenge that defies simple solutions and requires multisectoral coordination and interdisciplinary collaboration. National action plans (NAPs), which are built on the template of the World Health Organization's Global Action Plan on AMR, offer a critical framework for addressing AMR. However, the lack of measurable targets within many NAPs hinders progress in mitigating AMR and setting up accountability and monitoring frameworks for tracking implementation progress. In this perspective article, we argue that establishing national targets within NAPs will be a critical step towards the effective mitigation of AMR. We selectively review the current landscape of targets in existing NAPs, reflect on the importance of establishing context-specific AMR targets and identify early successes in AMR target development. Finally, we present recommendations for developing clear, measurable, and achievable targets in NAPs to improve AMR outcomes. We finally suggest that success requires not only strong political will but also sustained investments in integrated surveillance infrastructure to facilitate multi-sectoral policy coordination and collaboration in target setting processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.